Treace Medical Concepts Inc reports results for the quarter ended June 30 - Earnings Summary

• Treace Medical Concepts Inc TMCI.OQ reported a quarterly adjusted loss of 28 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -29 cents. The mean expectation of six analysts for the quarter was for a loss of 29 cents per share. Wall Street expected results to range from -31 cents to -26 cents per share.

• Revenue rose 6.6% to $47.39 million from a year ago; analysts expected $47.05 million.

• Treace Medical Concepts Inc's reported EPS for the quarter was a loss of 28 cents​.

• The company reported a quarterly loss of $17.4 million.

• Treace Medical Concepts Inc shares had fallen by 7.0% this quarter and lost 26.5% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 0.6% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

• Wall Street's median 12-month price target for Treace Medical Concepts Inc is $9.00, about 36.9% above its last closing price of $5.68

This summary was machine generated from LSEG data August 8 at 03:52 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)